ArticleJournal of neural transmission (Vienna, Austria : 1996)2026
Remote smartphone-based spoken language screening predicts clinical markers in Huntington's disease.
Article in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Assessment and monitoring of Huntington's disease (HD) symptoms remain limited to infrequent, clinic-based evaluations. We evaluated whether fully automated linguistic analysis of speech tasks recorded via smartphone can remotely capture core clinical markers of HD severity. In this cross-sectional multicenter study across Czech and German sites, 53 participants, including 30 HD (9 pre-symptomatic, 3 prodromal, and 18 manifest) and 23 healthy controls, completed a smartphone-based speech assessment, including spontaneous monologue and fairy tale retelling for 7 consecutive days. Recordings were automatically transcribed and analyzed using natural language processing to derive 3 lexical and 3 syntactic features. Predictive models for clinical outcomes based on the Unified Huntington's Disease Rating Scale and cognitive scales were built using multivariate linear regression with cross-validation. Linguistic features predicted HD severity across multiple domains with high predictive performance, explaining up to 57% of the variance in cognitive performance, 63% in motor impairment, and 59% in functional capacity. A median of 6 days for monologue and 3 for retelling was sufficient to reach 90% of maximal predictive performance. Compared to controls, HD participants showed reduced vocabulary range and increased phrase repetition in both tasks (p < 0.05), with additional monologue-specific deficits in sentence length (p = 0.018) and syntactic complexity (p = 0.004). Fully automated analysis of smartphone-based language assessment can remotely quantify cognitive, motor, and functional impairment in HD, offering a scalable, low-burden digital biomarker for clinical trials and decentralized monitoring.
Indexed as
Identifiers
42133013What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.